FDA关于致癌性试验“特别方案评估”的流程和相关法规的介绍与探讨
黄丽, 张素才, 戴学栋, 孙云霞, 孙涛, 姚大林
中国药事 ›› 2020, Vol. 34 ›› Issue (9) : 1063-1069.
FDA关于致癌性试验“特别方案评估”的流程和相关法规的介绍与探讨
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Introduction and Exploration on the Process and the Related Regulations of "Special Protocol Assessment" for Carcinogenicity Test by FDA
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
